NO20075153L - Terapeutisk anvendelse av nefopam og analoger derav - Google Patents

Terapeutisk anvendelse av nefopam og analoger derav

Info

Publication number
NO20075153L
NO20075153L NO20075153A NO20075153A NO20075153L NO 20075153 L NO20075153 L NO 20075153L NO 20075153 A NO20075153 A NO 20075153A NO 20075153 A NO20075153 A NO 20075153A NO 20075153 L NO20075153 L NO 20075153L
Authority
NO
Norway
Prior art keywords
nefopam
analogs
therapeutic use
fibromyalgia
fatigue
Prior art date
Application number
NO20075153A
Other languages
English (en)
Inventor
Michael Harvey Lyne
Robin Mark Bannister
Original Assignee
Sosei R & D Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sosei R & D Ltd filed Critical Sosei R & D Ltd
Publication of NO20075153L publication Critical patent/NO20075153L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/5545—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having eight-membered rings not containing additional condensed or non-condensed nitrogen-containing 3-7 membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Nutrition Science (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

Nefopam eller en analog derav med generell formel: er nyttig ved behandling av et syndrom som er karakterisert ved kronisk smerte og tretthet, for eksempel fibromyalgi.
NO20075153A 2005-04-04 2007-10-10 Terapeutisk anvendelse av nefopam og analoger derav NO20075153L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0506835.8A GB0506835D0 (en) 2005-04-04 2005-04-04 Therapeutic use of nefopam
PCT/GB2006/001197 WO2006106308A1 (en) 2005-04-04 2006-03-31 Therapeutic use of nefopam and analogues thereof

Publications (1)

Publication Number Publication Date
NO20075153L true NO20075153L (no) 2007-10-30

Family

ID=34586684

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20075153A NO20075153L (no) 2005-04-04 2007-10-10 Terapeutisk anvendelse av nefopam og analoger derav

Country Status (14)

Country Link
US (1) US20080255079A1 (no)
EP (1) EP1868597A1 (no)
JP (1) JP2008534663A (no)
KR (1) KR20070121032A (no)
CN (1) CN101171004A (no)
AU (1) AU2006231117A1 (no)
BR (1) BRPI0610663A2 (no)
CA (1) CA2604396A1 (no)
GB (1) GB0506835D0 (no)
IL (1) IL186426A0 (no)
MX (1) MX2007012300A (no)
NO (1) NO20075153L (no)
WO (1) WO2006106308A1 (no)
ZA (1) ZA200708641B (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2782472C (en) * 2009-12-15 2019-04-16 The Hospital For Sick Children Method of treating scars and beta-catenin-mediated disorders
RU2646495C2 (ru) * 2015-12-28 2018-03-05 Общество с ограниченной ответственностью "Научно-техническая производственная фирма "Анта-Медикал" Фармацевтические композиции в форме ректальных суппозиториев, содержащие нефопама гидрохлорид (варианты), их применение для лечения острого и хронического болевого синдрома и способы получения
US10736905B1 (en) 2016-09-09 2020-08-11 Shahin Fatholahi Nefopam dosage forms and methods of treatment
US11446311B2 (en) 2017-09-08 2022-09-20 Shahin Fatholahi Methods for treating pain associated with sickle cell disease
US10736874B1 (en) 2017-09-08 2020-08-11 Shahin Fatholahi Methods for treating pain associated with sickle cell disease
RU2661618C1 (ru) * 2017-11-23 2018-07-17 Общество с ограниченной ответственностью "Научно-техническая производственная фирма "Анта-Медикал" Суппозитории нефопама для лечения острого и хронического болевого синдрома на липофильной основе и способ их получения
RU2661617C1 (ru) * 2017-11-23 2018-07-17 Общество с ограниченной ответственностью "Научно-техническая производственная фирма "Анта-Медикал" Суппозитории нефопама для лечения острого и хронического болевого синдрома на гидрофильной эмульсионной основе и способ их получения
RU2723952C1 (ru) * 2019-11-12 2020-06-18 Геннадий Владимирович Несповитый Суппозитории для лечения болевого синдрома средней и высокой интенсивности
RU2723960C1 (ru) * 2019-11-12 2020-06-18 Геннадий Владимирович Несповитый Суппозитории для лечения болевого синдрома средней и высокой интенсивности
RU2723958C1 (ru) * 2019-11-12 2020-06-18 Геннадий Владимирович Несповитый Суппозитории для лечения болевого синдрома средней и высокой интенсивности
RU2723954C1 (ru) * 2019-11-12 2020-06-18 Геннадий Владимирович Несповитый Суппозитории для лечения болевого синдрома средней и высокой интенсивности

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006522012A (ja) * 2002-12-20 2006-09-28 アラキス リミテッド ベンゾキサゾシンおよびそのモノアミン再吸収阻害剤としての用途
EP1740558A1 (en) * 2004-04-21 2007-01-10 Sosei R&D Ltd. Benzoxazocines and their therapeutic use as monoamine reuptake inhibitors

Also Published As

Publication number Publication date
BRPI0610663A2 (pt) 2010-07-13
US20080255079A1 (en) 2008-10-16
WO2006106308A1 (en) 2006-10-12
MX2007012300A (es) 2007-12-13
KR20070121032A (ko) 2007-12-26
JP2008534663A (ja) 2008-08-28
EP1868597A1 (en) 2007-12-26
CN101171004A (zh) 2008-04-30
AU2006231117A1 (en) 2006-10-12
IL186426A0 (en) 2008-08-07
ZA200708641B (en) 2009-08-26
CA2604396A1 (en) 2006-10-12
GB0506835D0 (en) 2005-05-11

Similar Documents

Publication Publication Date Title
NO20075153L (no) Terapeutisk anvendelse av nefopam og analoger derav
NO20083036L (no) Anvendelse av benzofuserte heterocykliske sulfamidderivater for behandling av depresjon
NO20065260L (no) Tri(cyklo)substituerte amidforbindelser
NO20065847L (no) Difenylimidazopyrimidiner og -imidazolaminer som inhibitorer av B-sekretase
NO20073816L (no) Kombinasjonsterapi for behandling av diabetes og tilstander relatert dertil og for behandling av tilstanden som er bedret ved a oke blod GLP-1 nivaet
NO20074943L (no) Roflumilast for behandlingen av diabetes mellitus
NO20080084L (no) Molekyler som er i stand til a hemme bindingen mellom NGF og TrkA-reseptoren som analgetika med forlenget effekt
NO20082790L (no) Behandling av type 2 diabetes med en kombinasjon av DPIV inhibitor og metformin eller thiazolidindion
EA201101189A1 (ru) Ингибитор sglt-2, предназначенный для лечения сахарного диабета типа 1, сахарного диабета типа 2, нарушенной толерантности к глюкозе или гипергликемии
NO20082090L (no) Pyridopyrimidinoninhibitorer av P13K alfa
EA201200793A1 (ru) Лечение генотипированных пациентов с диабетом ингибиторами дпп-4, такими как линаглиптин
NO20091700L (no) Florizinanaloger som inhibitorer av glukose-ko-transporter 2
EA200801897A1 (ru) Ингибиторы mnk2 на основе 8-гетероарилпурина для лечения метаболических нарушений
CL2012003026A1 (es) Composicion farmaceutica que comprende pioglitazona y linagliptina; procedimiento de preparacion; uso en el tratamiento de la diabetes tipo 2 o la obesidad.
EA200870019A1 (ru) Лактамовые соединения и способы их применения
EA201100302A1 (ru) Лечение диабета у пациентов, для которых лечение метформином является неприемлемым
CA2634419C (en) Use of benzo-fused heterocycle sulfamide derivatives for lowering lipids and lowering blood glucose levels
MY145340A (en) Milnacipran for the long-term treatment of fibromyalgia syndrome
ATE534652T1 (de) Phosphono-pent-2-en-1-yl-nukleoside und analoga
BRPI0722054A2 (pt) Composição, kit, e métodos para diminuir um efeito colateral de tratamento com um inibidor da calcineurina, para aumentar um efeito terapêutico de um inibidor da calcineurina e para mudar a concentração de tacrolimus ou um análogo de tacrolimus em um compartimento fisiológico.
NO20082096L (no) Azaindol-2-karboksamidderivativer
EA201170672A1 (ru) Соединения, пригодные для лечения целлюлита
DOP2010000156A (es) Oxazolidinonas para el tratamiento y/o profilaxis de la insuficiencia cardiaca
CY1116166T1 (el) Νεα μεθοδος για την αντιμετωπιση λοιμωξεων απο η.pylori
EA200700102A1 (ru) Лечение невропатической боли, фибромиалгии или ревматоидного артрита

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application